Literature DB >> 8757332

Human gamma delta T cell subset-proliferative response to malarial antigen in vitro depends on CD4+ T cells or cytokines that signal through components of the IL-2R.

M M Elloso1, H C van der Heyde, A Troutt, D D Manning, W P Weidanz.   

Abstract

We examined the cellular and molecular basis of the proliferative response of human gamma delta T cells in cultures of PBMC stimulated with blood-stage Plasmodium falciparum malarial Ag. Flow cytometry revealed that maximal gamma delta T cell proliferation occurs after maximal CD4+ alpha beta T cell proliferation. Depletion of CD4+ T cells from PBMC before stimulation with malarial Ag markedly reduces the number of proliferating gamma delta T cells, which suggests that CD4+ T cells function in providing help to gamma delta T cells to respond to this parasite Ag. Removal of gamma delta T cells, however, did not alter the expansion of the CD4+ T cell subset. The addition of exogenous IL-2, IL-4, or IL-15 restored the capacity of gamma delta T cells to proliferate in Ag-stimulated cultures of PBMC depleted of CD4+ T cells. mAbs specific for the alpha- and beta-subunits of the IL-2 receptor inhibit the gamma delta T cell subset expansion in cultures stimulated with malarial Ag. Taken together, these findings suggest that the proliferation of gamma delta T cells in response to malarial Ag is dependent on the presence of CD4+ alpha beta T cells, but the requirement for CD4+ alpha beta T cells can be met by cytokines that use the IL-2R.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757332

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  The proportion of circulating gammadelta T cells increases after the first week of onset of tularaemia and remains elevated for more than a year.

Authors:  M Kroca; A Tärnvik; A Sjöstedt
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Splenic gammadelta T cells regulated by CD4+ T cells are required to control chronic Plasmodium chabaudi malaria in the B-cell-deficient mouse.

Authors:  Henri C van der Heyde; Joan M Batchelder; Matyas Sandor; William P Weidanz
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Murine gamma delta T lymphocytes elicited during Plasmodium yoelii infection respond to Plasmodium heat shock proteins.

Authors:  J Kopacz; N Kumar
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Gamma delta T-cell function in pathogenesis of cerebral malaria in mice infected with Plasmodium berghei ANKA.

Authors:  D M Yañez; J Batchelder; H C van der Heyde; D D Manning; W P Weidanz
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

5.  γδ T cells and immunity to human malaria in endemic regions.

Authors:  Samarchith P Kurup; John T Harty
Journal:  Ann Transl Med       Date:  2015-05

Review 6.  Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious diseases.

Authors:  Richard D Lopez
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

7.  Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination.

Authors:  Y Poquet; M Kroca; F Halary; S Stenmark; M A Peyrat; M Bonneville; J J Fournié; A Sjöstedt
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

8.  In vitro responsiveness of gammadelta T cells from Mycobacterium bovis-infected cattle to mycobacterial antigens: predominant involvement of WC1(+) cells.

Authors:  A J Smyth; M D Welsh; R M Girvin; J M Pollock
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

9.  Human cord blood γδ T cells expressing public Vγ2 chains dominate the response to bisphosphonate plus interleukin-15.

Authors:  Cristiana Cairo; Bertrand Sagnia; Giulia Cappelli; Vittorio Colizzi; Rose G F Leke; Robert J Leke; C David Pauza
Journal:  Immunology       Date:  2013-04       Impact factor: 7.397

Review 10.  T cell-mediated immunity to malaria.

Authors:  Noah S Butler; John T Harty; Samarchith P Kurup
Journal:  Nat Rev Immunol       Date:  2019-07       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.